Related Experiment Video
Updated: Dec 26, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Microvascular function and oxidative stress in adult individuals with early onset of cardiovascular disease
Hala Shokr1, Irundika H K Dias2, Doina Gherghel3
1Vascular Research Laboratory, School of Life and Health Sciences, Aston University, Birmingham, UK.
Insights
Early hypertensive changes show altered retinal vascular function and reduced systemic anti-oxidative capacity. These microvascular changes occur even at blood pressure levels considered normal, indicating early signs of cardiovascular risk.
Area of Science:
- Ophthalmology
- Cardiology
- Biochemistry
Background:
- Hypertension is a major risk factor for cardiovascular disease.
- Early detection of hypertensive changes is crucial for intervention.
- Retinal microvascular function may serve as an indicator of systemic vascular health.
Purpose of the Study:
- To investigate retinal vascular function in individuals with early hypertensive changes.
- To assess the relationship between retinal microvascular function and systemic anti-oxidative defence capacity.
- To compare these parameters in normal individuals versus those with early hypertension.
Main Methods:
- Dynamic retinal vessel analysis was used to assess microvascular function in 201 participants.
- Blood pressure, lipid panel, reduced glutathione (GSH), and oxidized glutathione (GSSG) were measured.
- Participants were categorized based on ESC/ESH guidelines for hypertension.
Main Results:
- Grade 1 hypertension showed significantly altered retinal arterial diameter fluctuation, dilation, constriction time, and slope.
- Individuals with high normal and grade 1 hypertension exhibited prolonged time to maximum arterial dilation.
- Reduced glutathione levels negatively correlated with blood pressure, while oxidized glutathione levels positively correlated.
Conclusions:
- Microvascular alterations are detectable at blood pressure levels still considered normal.
- These retinal changes parallel alterations in systemic oxidative stress levels.
- Retinal vascular function assessment may identify individuals at risk for hypertension and related complications early.
Abstract:
The current study aims to investigate retinal vascular function and its relationship with systemic anti-oxidative defence capacity in normal individuals versus those with early hypertensive changes according to the current ESC/ESH guidelines. Retinal microvascular function was assessed in 201 participants by means of dynamic retinal vessel analysis. Blood pressure, lipid panel, oxidized (GSH) & reduced glutathione (GSSG) were also evaluated for each participant. Individuals classed as grade 1 hypertension demonstrated higher retinal arterial baseline diameter fluctuation (p = 0.0012), maximum dilation percentage (p = 0.0007), time to maximum constriction (p = 0.0003) and lower arterial constriction slope (p = 0.0131). Individuals classed as high normal and grade 1 hypertension also demonstrated higher time to maximum dilation than individuals classed as optimal or normal. GSH levels correlated negatively with SBP, DBP and MBP values in all participants (p = 0.0010; p = 0.0350 and p = 0.0050) as well as with MBP values in high normal and grade 1 hypertension (p = 0.0290). The levels of GSSG correlated positively with SBP, DBP and MBP values in all participants (p = 0.0410; p = 0.0330 and, p = 0.0220). Our results point to the fact that microvascular alterations can be identifiable at BP values still considered within normal values and go in parallel with the changes observed in the level of oxidative stress.
More Related Videos
08:21Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
08:35Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology